Brief: Mithra Announces Sales Of Shares In Mayne Pharma

Mithra Pharmaceuticals SA

16/06/2023 08:17

June 16 (Reuters) - Mithra Pharmaceuticals SA
 MITRA.BR :
    * MITHRA ANNOUNCES SALE OF SHARES IN MAYNE PHARMA
    * SELLS 4,221,815 SHARES TO REDUCE STAKE IN MAYNE PHARMA TO
4.96%
    * SHARES ACQUIRED AS PART OF AGREEMENT ON US
COMMERCIALIZATION OF
ESTELLE®
    * REMAINS MAJOR SHAREHOLDER IN MAYNE PHARMA
    * ANNOUNCES SALE OF 4,221,815 SHARES IN MAYNE PHARMA GROUP
LIMITED
(ASX: MYX) AT A PRICE OF A$3.86 PER SHARE, IN LINE WITH MAYNE
PHARMA'S LAST CLOSE (IE 0% DISCOUNT)
    * SETTLEMENT IS EXPECTED TO TAKE PLACE AT T+2 BUSINESS DAYS
    * STAKE NOW CORRESPONDS TO 4.96% OF OUTSTANDING SHARES IN
MAYNE
PHARMA LISTED ON ASX, FROM PREVIOUS 9.93%
    * COMPANY HAS NO INTENTION TO DIVEST ITS CURRENT
PARTICIPATION IN
MAYNE PHARMA

Source text for Eikon:  ID:nNDL7BFkPT 
Further company coverage:  MITRA.BR 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))